An Audit of Patients With Crohn's Disease Treated With Infliximab (P06066)

Inclusion Criteria

• •Diagnosis of Crohn's Disease.
• •Over the age of 18 years.
• •Must have received the first infusion of infliximab on or after 1st January 2003 (when the maintenance therapy license was granted).
• •Must have received at least one infusion of infliximab.
• •A minimum of 12 months data prior to, and 24 months data post infliximab exposure should be available in the medical records.
• •Must have been under the care of the participating center for the entirety of the study period.